Clinical Pain Advisor Contributing Writer

In this interview, Gregory P Nicholson, MD, discusses the applications of a novel joint preservation technology in glenohumeral osteoarthritis.

Investigators examine the role of miRNAs in migraine, including understanding its pathogenesis, the population at risk, diagnosis, patient stratification, chronification risk factors, response to treatments, and miRNA-based therapeutic options.

In Denmark, investigators found data that showed many factors that were linked to treatment-resistant depression, including cohabitation, migraine, and so on.

Patients with opioid use disorder (OUD) who receive medications for OUD following endocarditis may experience improved health-related outcomes.

The threshold for pain interfering with daily activities was reported to be 3 on a 0 to 10 numeric rating scale by patients with rheumatoid arthritis.

Researchers sought to find any genetic variants associated with migraine or MS that could be identified from genome-wide association studies.

Fatigue, anemia, pain, and sleep disorders form part of the prodrome in MS.

Telephone-based motivational interviewing may improve a patient’s rate of initiating behavioral therapy for treatment of migraine.

In recent years, a number of preclinical models have shown that cannabinoids may be highly effective at improving inflammation and, therefore, may be a potential treatment for inflammatory bowel diseases.

Higher photophobia scores have been observed among individuals with migraine with aura compared with those who have migraine without aura.